company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10379000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10379000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,207000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,20000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1999000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1296000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9449000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9449000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-10000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,108000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,98000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,98000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9470000.0
Acceleron Pharma Inc,XLRN,,0001280600,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,425000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1647000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1647000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1380000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4004000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-286000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-286000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1101000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 09:01:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,435000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13078000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,225000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,159000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1150000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24624000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10012000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10012000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10045000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18513000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18513000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11605000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-868000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7539000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7539000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-62000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-62000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-62000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1815000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,97406000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,95615000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,95615000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,88014000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,412000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18110000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18110000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,234000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1536000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1364000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1364000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1854000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-581000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,603000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1832000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1832000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3316000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,395000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9120000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,265000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3633000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12472000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12472000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-150000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16332000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,129166000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,760000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,113594000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,113594000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,100972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:26:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16550000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16550000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,277000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5249000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,251000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10773000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10773000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-229000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-229000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-229000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1117000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1117000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1117000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9885000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7972000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,290000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7323000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1351000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16356000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16356000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1472000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1481000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1481000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14994000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,286000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-536000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4974000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-726000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13619000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13619000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,839000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,839000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,839000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12796000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14574000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,291000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1041000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2039000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-540000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13825000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13825000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-158000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124216000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-124374000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-124374000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,307000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1246000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1553000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1553000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:35:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-136646000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10381000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10381000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,283000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,264000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,225000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,661000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8948000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8948000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8493000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14985000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6406000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6406000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,884000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,884000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,884000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1658000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11857000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11857000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,297000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,777000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-95000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1901000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8977000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8977000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-415000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1619000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15153000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,283000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,857000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1140000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1140000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5282000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27082000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27082000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,305000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12543000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1773000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12461000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12461000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-369000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-3453000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4122000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4122000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-47000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,976000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,928000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,928000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15655000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5061000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5061000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,324000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-100000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4435000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,89000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,939000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,939000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-489000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125524000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19096000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106917000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106917000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,141144000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,732000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,141876000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,141876000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:00:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35898000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22017000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22017000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,391000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-332000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7397000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1349000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15910000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15872000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1071000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35274000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25082000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11263000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11263000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-369000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,818000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,449000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,449000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26686000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20769000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20769000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,443000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,432000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5137000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1773000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12984000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13022000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-686000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,28233000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-23058000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4489000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4489000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,580000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1974000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2554000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2554000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,518000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3092000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-911000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16590000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16590000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1134000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-85749000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91769000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4886000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4886000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1788000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1788000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1788000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9916000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,541000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6716000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3613000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21763000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21763000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-677000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-221000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33533000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32635000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32635000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,510000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1011000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1521000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1521000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:19:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12393000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29668000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29668000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,683000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9873000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1951000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17161000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17161000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2251000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,46000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16688000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14483000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14483000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,247000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,247000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,247000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25451000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25451000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,799000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6182000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1652000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16818000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16818000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-711000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34999000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34999000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,188303000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2201000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,190504000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,190052000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,208233000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27928000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27928000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7126000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20802000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20802000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-757000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-179690000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33964000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-146483000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-146483000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28476000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-138809000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26219000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26219000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,904000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5784000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3900000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-504000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35947000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24530000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11921000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11921000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:12:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30414000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28937000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28937000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,962000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6680000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-856000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22151000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22151000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-869000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30166000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61017000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,29982000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,29982000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2025000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2025000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2025000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9856000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28980000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28980000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1002000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6682000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20096000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20096000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-528000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7457000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53084000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,45099000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,45099000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8297000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8297000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8297000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33300000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34735000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,879000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5832000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1004000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29028000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29028000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-689000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60456000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,59767000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,59767000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-139000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1025000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,886000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,886000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31625000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38053000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38053000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,933000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7868000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2944000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26308000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26308000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-587000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-216116000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64133000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-152570000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-152570000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,248155000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1161000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,249316000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,249316000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:14:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,70438000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17860000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17860000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1009000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5168000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2517000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14200000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-686000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77797000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40068000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38415000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38415000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-25000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1759000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1734000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1734000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50881000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,990000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4789000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2546000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37045000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37045000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-893000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-85183000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,124057000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37981000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37981000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5933000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23575000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23575000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1009000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5108000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1207000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16251000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16251000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1121000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16042000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,98876000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,81713000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,81713000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2673000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2673000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2673000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68135000.0
